Reflect Scientific Inc. develops advanced cryogenic cooling and refrigeration technologies for customers that require ultra-low-temperature storage, rapid freezing, and cold-chain support. Company news commonly covers orders and installations for B-90 blast freezers, liquid nitrogen freezer systems, and other high-performance cooling products used by pharmaceutical, biotechnology, vaccine storage, and logistics customers.
Recurring updates also address patented cryogenic cooling applications for data centers and server rooms, operating-cost initiatives, contract manufacturing relationships, and OTC market disclosure status. The company’s announcements center on product adoption, precision temperature-control use cases, and business changes tied to its cryogenic technology platform.
Reflect Scientific Inc. (RSCF) reported a 23.7% increase in sales for the fourth quarter of 2020, totaling $695,823, compared to $562,314 in the same quarter of 2019. This growth was primarily driven by the Cryometrix ULT freezer product line. CEO Kim Boyce expressed satisfaction with the annual sales performance, stating the year ended on a positive note.
Reflect Scientific specializes in innovative cryogenic cooling technologies for the biotechnology, pharmaceutical, and transportation sectors.
Reflect Scientific, Inc. (RSCF) announced strong orders of $231K for its Cryometrix ultra-low temperature freezers, indicating robust demand in January 2021. CEO Kim Boyce noted that these freezers are becoming vital for the cold chain management in pharmaceuticals. The Cryometrix series employs patented liquid nitrogen cooling technology, offering superior reliability and performance compared to traditional freezers, with capacities ranging from 120 to 950 liters.
Reflect Scientific, Inc. (Symbol: RSCF) has launched a new ultra-low temperature freezer, the Cryometrix RDC-120, designed for efficient storage of vaccines and high-value biologicals. This freezer features patented liquid nitrogen cooling technology and can operate in a transportable, self-powered configuration. With a capacity of approximately 120 liters and a temperature range of 0C to -160C, it cools from room temperature to -80C in just 5 minutes. CEO Kim Boyce emphasized the freezer's versatility, making it suitable for various deployment scenarios. Orders for the RDC-120 are now being accepted.
Reflect Scientific has been awarded a patent for its Cryometrix S-90, a cryogenic shipping unit capable of maintaining temperatures as low as -90 degrees Celsius. This system enhances cold chain management for biologics, including COVID-19 vaccines, by eliminating the need for dry ice and ensuring temperature uniformity during transport.
The S-90 can ship up to 33.5 cubic feet (70,000 vials) of product, featuring advanced temperature logging and customizable settings. Reflect Scientific specializes in cryogenic cooling technologies for the biotechnology and pharmaceutical industries.
Reflect Scientific, Inc. (Symbol: RSCF), based in Orem, Utah, focuses on innovative cryogenic cooling technologies for the biotechnology, pharmaceutical, and transportation sectors. Their Cryometrix 53-foot reefer trailer is designed to replace traditional diesel systems with a pollution-free refrigeration alternative. The CB-40 TRU features a patented self-contained liquid nitrogen cooling system, ensuring reliable temperature control with minimal maintenance. Recent successful tests demonstrated its efficiency in transporting perishable goods over long distances, showcasing its potential for critical cold chain logistics.
Reflect Scientific, Inc. (Symbol: RSCF) provided its annual business update, showcasing a 243% increase in product sales for the year ending June 30, 2020, compared to the same period in 2019. The company has invested in manufacturing infrastructure and revamped its corporate structure to reduce overheads. Reflect Scientific has entered the CBD oil market, reporting strong sales and repeat business. They are also expanding their market reach with new distributor partnerships. The company remains debt-free with significant cash reserves, self-funding all initiatives.